HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 159 filers reported holding HERON THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $29,873,000 | +16.9% | 1,606,942 | +53.7% | 1.75% | +9.7% |
| Q1 2019 | $25,550,000 | -7.1% | 1,045,392 | -1.4% | 1.59% | -24.5% |
| Q4 2018 | $27,491,000 | +2.8% | 1,059,792 | +25.4% | 2.11% | +42.8% |
| Q3 2018 | $26,746,000 | -23.8% | 845,042 | -6.5% | 1.48% | -26.0% |
| Q2 2018 | $35,115,000 | -14.7% | 903,857 | -39.4% | 1.99% | -6.0% |
| Q1 2018 | $41,167,000 | +52.2% | 1,491,569 | -0.2% | 2.12% | +70.8% |
| Q4 2017 | $27,044,000 | +11.5% | 1,494,175 | -0.5% | 1.24% | +16.2% |
| Q3 2017 | $24,244,000 | +8.6% | 1,501,177 | -6.9% | 1.07% | +12.4% |
| Q2 2017 | $22,327,000 | -9.5% | 1,612,102 | -1.9% | 0.95% | -24.2% |
| Q1 2017 | $24,662,000 | +20.5% | 1,644,152 | +5.2% | 1.25% | +30.5% |
| Q4 2016 | $20,473,000 | +82.6% | 1,562,817 | +140.2% | 0.96% | +180.2% |
| Q3 2016 | $11,212,000 | – | 650,731 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |